Inventor · disambiguated record
Martin Friedlander
Also filed as: FRIEDLANDER MARTIN
15 granted patents·20 pending applications·563 citations·filing 1997–2011
94Inventor score
Top patents by PatentIndex Score
35 records- 0198US8017593B2Tryptophanyl-tRNA synthetase-derived polypeptides useful for the regulation of angiogenesisSCRIPPS RESEARCH INST·Filed 2009·Granted Sep 13, 2011·100 cites·18 claims
- 0298US7476651B2Tryptophanyl-tRNA synthetase-derived polypeptides useful for the regulation of angiogenesisSCRIPPS RESEARCH INST·Filed 2007·Granted Jan 13, 2009·102 cites·17 claims
- 0398US7413885B2Tryptophanyl-tRNA synthetase-derived polypeptides useful for the regulation of angiogenesisSCRIPPS RESEARCH INST·Filed 2007·Granted Aug 19, 2008·100 cites·20 claims
- 0498US7273844B2Tryptophanyl-tRNA synthetase-derived polypeptides useful for the regulation of angiogenesisSCRIPPS RESEARCH INST·Filed 2004·Granted Sep 25, 2007·108 cites·10 claims
- 0592US7528106B2Compositions and methods for treatment of neovascular diseasesSCRIPPS RESEARCH INST·Filed 2005·Granted May 5, 2009·96 cites·1 claims
- 0689US7645736B2Integrin inhibitors for the treatment of eye diseasesMERCK PATENT GMBH·Filed 2006·Granted Jan 12, 2010·17 cites·23 claims
- 0788US7648959B2Methods and compositions for the treatment of diseases of the eyeMERCK PATENT GMBH·Filed 2006·Granted Jan 19, 2010·16 cites·17 claims
- 0875US7153501B2Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewithSCRIPPS RESEARCH INST·Filed 2003·Granted Dec 26, 2006·8 cites·3 claims
- 0969US8900567B2Treatment of cone cell degeneration with transfected lineage negative hematopoietic stem cellsFRIEDLANDER MARTIN·Filed 2007·Granted Dec 2, 2014·2 cites·12 claims
- 1065US7931891B2Isolated myeloid-like bone marrow cell populations and methods of treatment therewithSCRIPPS RESEARCH INST·Filed 2006·Granted Apr 26, 2011·1 cites·11 claims
- 1165US7838290B2Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewithSCRIPPS RESEARCH INST·Filed 2004·Granted Nov 23, 2010·3 cites·3 claims
- 1261US7419953B2Selective R-cadherin antagonist and methodsSCRIPPS RESEARCH INST·Filed 2004·Granted Sep 2, 2008·1 cites·2 claims
- 1361US2006165703A1Methods and compositions useful for inhibition of alpha v beta 5 mediated angiogenesisSCRIPPS RESEARCH INST·Filed 2005·Application pending·0 cites
- 1459US7053041B1Methods and compositions useful for inhibition of αvβ5mediated angiogenesisSCRIPPS RESEARCH INST·Filed 1997·Granted May 30, 2006·9 cites·42 claims
- 1558US8796237B2Tryptophanyl-tRNA synthetase-derived polypeptides useful for the regulation of angiogenesisSCHIMMEL PAUL·Filed 2011·Granted Aug 5, 2014·0 cites·22 claims
- 1657US8163697B2Selective R-cadherin antagonists and methodsFRIEDLANDER MARTIN·Filed 2008·Granted Apr 24, 2012·0 cites·2 claims
- 1756US2010303768A1Isolated lineage negative hematopoietic stem cells and methods of treatment therewithSCRIPPS RESEARCH INST·Filed 2008·Application pending·0 cites
- 1855US2009285792A1Compositions and methods for treatment of neovascular diseasesSCRIPPS RESEARCH INST·Filed 2009·Application pending·0 cites
- 1954US2007116685A1Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewithSCRIPPS RESEARCH INST·Filed 2006·Application pending·0 cites
- 2052US2004198644A1Integrin inhibitors for the treatment of eye diseasesFiled 2002·Application pending·0 cites
- 2150US2006104963A1Treatment of cone cell degeneration with transfected lineage negative hematopoietic stem cellsSCRIPPS RESEARCH INST·Filed 2005·Application pending·0 cites
- 2250US2005129665A1Isolated lineage negative hematopoietic stem cells and methods of treatment therewithFiled 2004·Application pending·0 cites
- 2350US2005085415A1Methods and compositions for the treatment of eye diseasesFiled 2003·Application pending·0 cites
- 2445US2007231306A1Isolated myeloid-like cell populations and methods of treatment therewithSCRIPPS RESEARCH INST·Filed 2006·Application pending·0 cites
- 2545US2004029788A1Methods and compositions for the treatment of diseases of the eyeFiled 2001·Application pending·0 cites
- 2644US2006104962A1Transfected hematopoietic stem cells and methods of treatment of neovascular eye diseases therewithSCRIPPS RESEARCH INST·Filed 2005·Application pending·0 cites
- 2744US2007207154A1Method of modulating vascularizationFRIEDLANDER MARTIN·Filed 2005·Application pending·0 cites
- 2843US2011104131A1Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewithSCRIPPS RESEARCH INST·Filed 2010·Application pending·0 cites
- 2941US2003017564A1Tryptophanyl-tRNA synthetase derived polypeptides useful for the regulation of angiogenesisFiled 2002·Application pending·0 cites
- 3041US2008317721A1Method for the Treatment of Retinopathy of Prematurity and Related Retinopathic DiseasesSCRIPPS RESEARCH INST·Filed 2006·Application pending·0 cites
- 3137US2008193435A1Revascularization of Ischemic Retinal Tissue and Screening Method ThereforFRIEDLANDER MARTIN·Filed 2006·Application pending·0 cites
- 3235US2010254952A1Isolated myeloid-like cell populations and methods of treatment therewithSCRIPPS RESEARCH INST·Filed 2010·Application pending·0 cites
- 3334US2011201108A1Isolated myeloid-like bone marrow cell populations and methods of treatment therewithFRIEDLANDER MARTIN·Filed 2011·Application pending·0 cites
- 3434US2002193327A1Vectors for occular transduction and use therefor for genetic therapySCRIPPS RESEARCH INST·Filed 2001·Application pending·0 cites
- 3528US2012009166A1Isolated monocyte populations and related therapeutic applicationsFRIEDLANDER MARTIN·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Martin Friedlander files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →